Hepatoma, Morris
|
0.300 |
Biomarker
|
disease |
CTD_human |
Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages.
|
21035526 |
2011 |
Hepatoma, Novikoff
|
0.300 |
Biomarker
|
disease |
CTD_human |
Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages.
|
21035526 |
2011 |
Liver Neoplasms, Experimental
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages.
|
21035526 |
2011 |
Experimental Hepatoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages.
|
21035526 |
2011 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Furthermore, Silencing of LDHA counteracted the effects of miR-383 suppression, while its overexpression reversed tumor inhibitory effects of miR-383.
|
28043152 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The present study concluded that miR-383-5p was downregulated and may act as a tumor suppressor in GC.
|
31637133 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In vivo experiments also revealed that tumor growth could be inhibited by miR-383-5p mimic.
|
30399596 |
2019 |
Tumor Cell Invasion
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
In the end, it was proved that LINC01128 could enhance cell proliferation, migration and invasion as well as inhibit cell apoptosis by binding with miR-383-5p and upregulating SFN.
|
31779593 |
2019 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
In the present study, we indicated that LINC00096 might promote the proliferation and invasion through regulating the miR-383-5p/RBM3 pathway in TNBC, which providing a novel therapeutic target for cancer treatment.
|
31819536 |
2019 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Long noncoding RNA HOXC13-AS positively affects cell proliferation and invasion in nasopharyngeal carcinoma via modulating miR-383-3p/HMGA2 axis.
|
30536950 |
2019 |
Tumor Cell Invasion
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Ectopic expression of miR-383 remarkably suppressed the ovarian cancer cell proliferation by enhancing cell apoptosis and significantly inhibited the invasion of ovarian cancer cells, while low expression of miR-383 exhibited the opposite effect.
|
28043152 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Finally, we demonstrated that stable over expression of miR-383 in colon cancer cells decreased the growth of the tumors.
|
29938829 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Besides, the addition of miR-383 decreased the tumor volume and size and inhibited the expressions of Wnt1, β-catenin, and cyclin D1 at the protein level in nude mice.
|
30426539 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In conclusion, miR-383 serves as a tumor-suppressive miR to regulate cholangiocarcinoma cell proliferation, migration, and invasion via directly targeting IRF1.
|
30145803 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Low miR‑383 expression was negatively associated with tumour size, lymph node metastasis and TNM stage.
|
29512711 |
2018 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
In conclusion, miR-383 serves as a tumor-suppressive miR to regulate cholangiocarcinoma cell proliferation, migration, and invasion via directly targeting IRF1.
|
30145803 |
2018 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Transfection with a miR-383 mimic suppressed proliferation and inhibited cell migration and invasion in HT-29 and LoVo colon cancer cell lines.
|
29399173 |
2018 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
MicroRNA-383 suppresses cell proliferation and invasion in colorectal cancer by directly targeting paired box 6.
|
29512711 |
2018 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Subsequent functional study in HTR-8/SVneo and HUVEC cells indicated that MALAT1 modulates the cell proliferation, apoptosis, migration and invasion via directly interact with miR-383, miR-15, miR-205 and miR-375.
|
30173780 |
2018 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
This study aims to evaluate the effect of the regulatory relationship between microRNA-383 (miR-383) and PARP2 in the cell migration and invasion in human with cervical cancer (CC) via the PI3K-AKT-MTOR signaling pathway.
|
29236322 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Also, the susceptibility of miR-383 as a tumor marker and the relationship between its aberrant expression and clinicopathological features were determined. qRT-PCR data showed that miR-383 was dysregulated during gastric tumorigenesis.
|
28243881 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Our study proved that miR-383 is down-regulated in HCC and acts as a tumor suppressor through targeting LDHA.
|
28293396 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
MiR-383 was overexpressed in both immortal EOC cell lines and human EOC tumors.
|
27567588 |
2016 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
MiR-383 was upregulated in A549 and H596 cells to evaluate its tumor suppressive effect on NSCLC proliferation, invasion and migration in vitro.
|
27551765 |
2016 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Moreover, miR-383 expression in HCC was significantly correlated with tumor size and tumor-node-metastasis (TNM) stage.
|
26385772 |
2016 |